Alignment Healthcare News

Piper Sandler Downgrades Alignment Healthcare to Neutral, Lowers Price Target to $6

BenzingaMar 6 09:17 ET

The Latest Analyst Ratings For Alignment Healthcare

BenzingaMar 6 09:00 ET

Alignment Healthcare Analyst Ratings

BenzingaMar 6 06:02 ET

Buy Rating Affirmed for Alignment Healthcare Amidst Strong Q4 Performance and Positive 2024 Outlook

TipRanksMar 1 01:06 ET

Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD)

TipRanksFeb 29 05:40 ET

UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating

MT NewswiresFeb 28 12:59 ET

Alignment Healthcare (ALHC) Receives a Buy From TD Cowen

TipRanksFeb 28 07:48 ET

Alignment Healthcare Analyst Ratings

BenzingaJan 24 05:31 ET

Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating

MT NewswiresJan 9 09:51 ET

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Alignment Healthcare (ALHC) and 10x Genomics (TXG)

TipRanksJan 9 05:11 ET

Alignment Healthcare Analyst Ratings

BenzingaJan 9 05:05 ET

Alignment Healthcare (ALHC) Gets a Buy From Goldman Sachs

TipRanksJan 8 11:45 ET

Alignment Healthcare Analyst Ratings

BenzingaDec 21, 2023 10:14 ET

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Adverum Biotechnologies (ADVM) and Alignment Healthcare (ALHC)

TipRanksNov 8, 2023 00:51 ET

Analysts' Top Healthcare Picks: GlycoMimetics (GLYC), Alignment Healthcare (ALHC)

TipRanksNov 3, 2023 10:20 ET

Alignment Healthcare Analyst Ratings

BenzingaNov 2, 2023 08:34 ET

Raymond James Upgrades Alignment Healthcare to Strong Buy, Raises Price Target to $10

BenzingaOct 16, 2023 05:15 ET

Alignment Healthcare Analyst Ratings

BenzingaOct 16, 2023 05:13 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alignment Healthcare (ALHC) and BioNTech SE (BNTX)

TipRanksOct 16, 2023 04:40 ET

Stephens & Co. Initiates Coverage On Alignment Healthcare With Equal-Weight Rating, Announces Price Target of $9

BenzingaOct 12, 2023 10:27 ET